Reston, VA—Nearly 70 percent of breast cancer patients could find out if their cancer has spread to their lymph nodes without having to undergo an invasive sentinel node biopsy. New research published ...
Impact of trial site selection on minority patient recruitment in prostate cancer trials. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full ...
The BOOG 2013-08 trial evaluates whether SLNB can be safely omitted for patients with clinically T1-2N0 treated with ...
Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...
Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...
Slightly more women 70 years or older with these early breast cancers had chemo-qualifying Oncotype DX 21-gene recurrence scores (>26) if node positive than if node ...
The Melanoma Institute of Australia (MIA) previously developed a risk calculator for sentinel lymph node (SLN) metastasis risk to help clinicians and patients with primary cutaneous melanoma decide ...
Omitting sentinel lymph node biopsy (SLNB) in patients with early-stage breast cancer undergoing breast-conserving surgery may not increase the risk for recurrence over 5 years, according to findings ...
Dr. Eva Singletary answers the question: 'What Effect Does Blue Dye Have?' — -- Question: What type of reactions are possible from the blue dye used in sentinel lymph node biopsy? Answer: The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback